Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
160 participants
INTERVENTIONAL
2022-02-07
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pivotal Study to Assess the InSpace™ Device for Treatment of Full Thickness Massive Rotator Cuff Tears
NCT02493660
InSpace™ System Over Rotator Cuff Repair in Comparison to Repair Alone.
NCT02210910
InSpace™ System Implantation in a Procedure Under Local Anesthesia
NCT02208453
InSpace™ System in Comparison to Best Repair of Massive Rotator Cuff Tear
NCT02211183
InSpace™ System in Comparison to Best Repair of Massive Rotator Cuff Tear.
NCT02208440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary:
• To evaluate clinical outcomes of both a formalized or an at-home rehabilitation program when used in conjunction with the InSpace device as compared to the corresponding InSpace Pivotal study results.
* To demonstrate consistency of each intervention group with the corresponding historical control study results.
* To demonstrate that comparable clinical outcomes can be achieved for each intervention group.
Secondary:
• Change in clinical outcomes compared to baseline.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
InSpace device + accelerated rehabilitation in a formalized program (FP)
InSpace Subacromial Tissue Spacer
Rotator Cuff Tear Treatment
Group II
InSpace device + accelerated rehabilitation in an at-home program (AHP)
InSpace Subacromial Tissue Spacer
Rotator Cuff Tear Treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
InSpace Subacromial Tissue Spacer
Rotator Cuff Tear Treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject has signed the IRB approved Informed Consent Form (ICF) specific to this study prior to enrollment
* Is male or female ≥ sixty-five (65) years of age
* Positive diagnostic imaging by MRI within 9 months of enrollment of the index shoulder indicating a full thickness MRCT:
* Measuring ≥ 5 cm in diameter
* Involving ≥ two tendons
* Functional deltoid muscle and preserved passive range of motion on physical examination
* Documented VAS score \> 30 mm pain
* Failed non-operative treatment of at least 3 months from the initial treatment to include one or more of the following:
* Oral analgesics
* Anti-inflammatory medication (e.g., ibuprofen, naproxen)
* Corticosteroid injection(s)
* Physical therapy
* Activity modification
* Rest (sling used)
* Must be able to read and understand the approved Informed Consent Form (written and oral)
* Must be in general good health (as determined by the Investigator) based on screening assessments and medical history
* Must be independent, ambulatory, and can comply with all post-operative evaluations, visits, and electronic database collection
Subjects MUST meet the following criteria to be randomized in the study:
* Full thickness tear
* Tear size ≥ 5 cm in diameter
* Tear involving ≥ two tendons
Exclusion Criteria
* Evidence of the following conditions:
* Severe gleno-humeral or acromio-humeral arthritis
* Full thickness cartilage loss as seen on MRI
* History within the past 5 years of anterior or posterior shoulder subluxation or dislocation as determined by history, examination, or radiographic findings
* Pre-existing deltoid defect or deltoid palsy
* Major joint trauma, infection, or necrosis
* Partial thickness tears of the supraspinatus
* Fully reparable rotator cuff tear \[Tear of less than 5 cm in diameter (or \< 4 cm2) with retractable tendon that can be fully repaired\]
* Known neurovascular compromise
* Complete deltoid muscle palsy
* Traumatic muscle tears of the pectoralis or deltoid
* The subject requires concomitant:
* Subscapularis repair
* Labral repair of any type
* Biceps tenodesis
* Previous surgery of the index shoulder in the past 1 year, excluding diagnostic arthroscopy
* The subject's condition is bilateral and rotator cuff repair is scheduled or to be scheduled over the course of this study for the contra lateral shoulder
* Major medical condition that could affect quality of life and influence the results of the study (e.g., rheumatoid arthritis)
* The subject has documented evidence of a history (e.g., liver testing) of drug/alcohol abuse within 12 months of enrollment
* The subject's condition represents a worker's compensation case
* The subject is currently involved in a health-related litigation procedure
* Females of child-bearing potential who are pregnant or plan to become pregnant.
* Concurrent participation in an investigational clinical study one month prior to enrollment or during the entire study period
* The subject is physically or mentally compromised (e.g., currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extent that the Investigator judges the subject to be unable or unlikely to remain compliant to follow-up
* The subject is receiving prescription narcotic pain medication for conditions unrelated to the index shoulder condition
* The subject currently has an acute infection in the area surrounding the surgical site.
* Baseline WORC score less than 420
* Rotator cuff is/presents with:
* Fully reparable with adequate tissue and muscle quality (equivalent to Goutallier stage 1 or 2)
* Partial thickness tear of the supraspinatus
* Evidence of significant osteoarthritis
* The subject requires concomitant:
* Subscapularis repair
* Labral repair of any type
* Biceps tenodesis
* Coracoacromial ligament functional deficiency or shoulder instability is identified
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stryker Endoscopy
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Colleen Roden, MS
Role: STUDY_DIRECTOR
Stryker Endoscopy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Musculoskeletal-Orthopedic Research and Education Foundation
Phoenix, Arizona, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Steadman Hawkins Clinic Denver
Englewood, Colorado, United States
Holy Cross Hospital
Fort Lauderdale, Florida, United States
Paley Orthopaedics & Spine
West Palm Beach, Florida, United States
Emory University
Atlanta, Georgia, United States
Rush University Medical Center
Chicago, Illinois, United States
Mayo Clinic
Rochester, Minnesota, United States
Hospital for Special Surgery
New York, New York, United States
The Rothman Institute
Philadelphia, Pennsylvania, United States
TSAOG Orthopaedics & Spine
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SYK-SM-2021-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.